Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
95223385 | 9522338 | 5 | F | 2013 | 20160630 | 20130913 | 20160715 | EXP | BR-JNJFOC-20130903678 | JOHNSON AND JOHNSON | 0.00 | A | F | Y | 59.00000 | KG | 20160715 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
95223385 | 9522338 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | Y | U | UNKNOWN | 0 | 3 | DF | LYOPHILIZED POWDER | |||||
95223385 | 9522338 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | Y | U | UNKNOWN | 0 | 5 | DF | LYOPHILIZED POWDER | |||||
95223385 | 9522338 | 3 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 3 VIALS | Y | U | UNKNOWN | 103772 | 3 | DF | LYOPHILIZED POWDER | ||||
95223385 | 9522338 | 4 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNSPECIFIED | ||||||||
95223385 | 9522338 | 5 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNSPECIFIED | ||||||||
95223385 | 9522338 | 6 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | 25 | UG | TABLET | ||||||||
95223385 | 9522338 | 7 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
95223385 | 9522338 | 8 | C | GLIFAGE | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
95223385 | 9522338 | 1 | Psoriatic arthropathy |
95223385 | 9522338 | 2 | Psoriatic arthropathy |
95223385 | 9522338 | 3 | Psoriatic arthropathy |
95223385 | 9522338 | 5 | Pain |
95223385 | 9522338 | 6 | Thyroid disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
95223385 | 9522338 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
95223385 | 9522338 | Arthropod sting | |
95223385 | 9522338 | Drug ineffective | |
95223385 | 9522338 | Gamma-glutamyltransferase increased | |
95223385 | 9522338 | Glucose tolerance impaired | |
95223385 | 9522338 | Nasopharyngitis | |
95223385 | 9522338 | Pain | |
95223385 | 9522338 | Psoriasis | |
95223385 | 9522338 | Psoriatic arthropathy | |
95223385 | 9522338 | Weight fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
95223385 | 9522338 | 1 | 20160321 | 20160519 | 0 | |
95223385 | 9522338 | 2 | 20090407 | 0 | ||
95223385 | 9522338 | 3 | 2008 | 0 | ||
95223385 | 9522338 | 5 | 2013 | 0 | ||
95223385 | 9522338 | 6 | 2005 | 0 |